Nasolacrimal Duct Obstruction Secondary to Radioactive Iodine-131 Therapy for Differentiated Thyroid Cancer

Nasolacrimal Duct Obstruction Secondary to Radioactive Iodine-131 Therapy for Differentiated Thyroid Cancer

Deterministic effects of medical exposure to ionising radiation can be associated with both the effectiveness of treatment and adverse drug reactions to it. The latter may drastically deteriorate the quality of life of a patient after radionuclide therapy. In addition, the regulations of the Russian...

Full description

Bibliographic Details
Main Authors:	A. A. Trukhin, V. D. Yartsev, M. S. Sheremeta, D. V. Yudakov, M. O. Korchagina, R. Kh. Salimkhanov, S. V. Grishkov
Format:	Article
Language:	Russian
Published:	NEICON ISP LLC 2022-12-01
Series:	Ведомости Научного центра экспертизы средств медицинского применения
Subjects:	iodine-131 nuclear medicine radionuclide therapy radionuclide diagnostics scintigraphy radiopharmaceuticals dacryology lacrimal ducts obliteration medical physics
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/502

Similar Items

The Effect of Radioactive Iodine (Iodine 131) on the Parameters of Sperm in Adult Male Rats
by: Fereshteh Dadfar, et al.
Published: (2018-10-01)

Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01)

Approach to radionuclide therapy dosimetry planning
by: Yu.V. Lysak, et al.
Published: (2016-12-01)

Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer
by: Sara Ahmadi, et al.
Published: (2022-05-01)

Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
by: G. E. Kodina, et al.
Published: (2022-10-01)

Masquerades of Acquired Dacryocystocele
by: Bothra N, et al.
Published: (2020-07-01)

Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2024-02-01)

Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy
by: Cyprine Neba Funeh, et al.
Published: (2023-04-01)

Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
by: Seyed Mohammad Javad Mortazavi, et al.
Published: (2023-01-01)

Utilización de hematíes marcados con 99mTc y desnaturalizados por calor en el diagnóstico gammagráfico de un caso infrecuente de esplenosis intratorácica
by: Mónica Romero Otero, et al.

Measurement of radiation doses absorbed in the thyroid cancer when treated with radioactive iodine 131I
by: Asema Mahmood Alemam
Published: (2013-06-01)

Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level
by: Vasily D Yartsev, et al.
Published: (2023-01-01)

Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
by: Min Joo Kim, et al.
Published: (2022-06-01)

Investigation of 131I kinetics in the rats organism after a single intake
by: I. P. Drozd, et al.
Published: (2012-09-01)

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated 131I dose
by: Ka Kit Wong, et al.
Published: (2018-11-01)

COMPLEX RADIONUCLIDE EVALUATION OF STRUCTURAL AND FUNCTIONAL STATE OF THE SINGLE KIDNEY IN CHILDREN
by: V. Kundin
Published: (2017-12-01)

Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review
by: Diogo Alpuim Costa, et al.
Published: (2023-09-01)

Highly Enriched Uranium-Free Medical Radioisotope Production Methods: An Integrative Review
by: Bruno Silveira Nunes, et al.
Published: (2022-12-01)

Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options
by: Burcu Altıparmak Güleç, et al.
Published: (2021-07-01)

Fundamental concepts of radiopharmaceuticals quality controls
by: Sajjad Molavipordanjani, et al.
Published: (2018-12-01)

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)
by: Licia Uccelli, et al.
Published: (2019-02-01)

What is the role of the bystander response in radionuclide therapies?
by: Darren eBrady, et al.
Published: (2013-08-01)

Integrated approach to radiodiagnosis of follicular thyroid neoplasia: a retrospective cohort trial
by: L. A. Timofeeva, et al.
Published: (2021-12-01)

Horseshoe kidney, complex radionuclide examination
by: Daryna Tertychna, et al.
Published: (2022-09-01)

Diagnostic role of radionuclide methods in patients with pyelonephritis
by: P.O. Korol
Published: (2018-10-01)

Recent Insights in Barium-131 as a Diagnostic Match for Radium-223: Cyclotron Production, Separation, Radiolabeling, and Imaging
by: Falco Reissig, et al.
Published: (2020-09-01)

Iodine 131 ablation of an obstructive lingual thyroid
by: Lester Johnson, et al.
Published: (2009-01-01)

Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
by: Emilie Thivat, et al.
Published: (2022-04-01)

Bacterial Detection Rate and Surgical Outcome in Povidone-Iodine Irrigation After Nasolacrimal Duct Intubation
by: Ishikawa S, et al.
Published: (2020-01-01)

External Dacryocystorhinostomy for the Treatment of Functional Nasolacrimal Drainage Obstruction
by: İlke Şimşek, et al.
Published: (2015-10-01)

Drug-induced liver injury caused by iodine-131
by: Chei Won Kim, et al.
Published: (2016-06-01)

Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
by: Xiaona Sun, et al.
Published: (2024-02-01)

Determinants of target absorbed dose in radionuclide therapy
by: Heribert Hänscheid, et al.
Published: (2023-02-01)

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
by: Romain Eychenne, et al.
Published: (2020-09-01)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
by: Holis Abdul Holik, et al.
Published: (2022-05-01)

<sup>67</sup>Cu Production Capabilities: A Mini Review
by: Liliana Mou, et al.
Published: (2022-02-01)

Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts
by: Muskan Goel, et al.
Published: (2023-02-01)

Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients
by: Raj Kumar Badam, et al.
Published: (2016-01-01)

Rapidly Increasing Artificial Iodine Highlights Pathways of Iceland-Scotland Overflow Water and Labrador Sea Water
by: Maxi Castrillejo, et al.
Published: (2022-05-01)

Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
by: Michele Klain, et al.
Published: (2021-09-01)